维A酸通过激活足细胞RARα改善肾毒性血清诱导的肾小球肾炎
本研究在肾毒性血清诱导的新月体性肾小球肾炎小鼠模型中,探讨维A酸(RA)是否通过足细胞维A酸受体α(RARα)保护足细胞。结果显示RA治疗明显改善野生型肾炎小鼠肾功能并减少新月体病变,而足细胞特异性敲除Rara后该保护作用大部分丧失。机制上RA主要经RARα介导保护足细胞,部分通过抑制壁上皮细胞增殖并诱导其向足细胞表型转分化。
要点
- RA改善肾炎小鼠肾功能并减少新月体,该保护作用依赖足细胞RARα。
- RA恢复足细胞分化标志物表达并抑制损伤、增殖及壁上皮细胞标志物。
- RA部分通过抑制壁上皮细胞增殖并促其向足细胞转分化发挥保护作用。
核心结论
- RA主要通过RARα介导的足细胞保护作用减轻新月体性肾小球肾炎,部分通过抑制壁上皮细胞增殖并诱导其转分化为足细胞。
研究设计与样本
- 研究采用肾毒性血清诱导的新月体性肾小球肾炎小鼠模型,比较野生型与足细胞特异性Rara敲除(Pod-Rara knockout)小鼠对RA治疗的反应。
主要发现
- RA治疗明显改善肾炎野生型小鼠肾功能并减少新月体病变数量,而足细胞特异性敲除Rara后该保护作用大部分丧失。
- RA显著恢复肾炎野生型小鼠足细胞分化标志物表达,但在肾炎Pod-Rara敲除小鼠中无此作用。
- RA抑制肾炎野生型小鼠细胞损伤、增殖及壁上皮细胞标志物表达,这些效应在Pod-Rara敲除小鼠中显著减弱。
- RA治疗使肾炎小鼠小部分肾小球细胞共表达足细胞与壁上皮细胞标志物,提示可能诱导壁上皮细胞向足细胞表型转分化。
- 体外RA直接抑制壁上皮细胞增殖并增强足细胞标志物表达;体内谱系追踪证实RA增加肾炎肾小球中表达足细胞标志物的壁上皮细胞数量。
临床怎么用
- 本研究为动物与体外实验,尚不能直接推导至临床用药;提示RARα通路可能是新月体性肾小球肾炎足细胞保护的可探索靶点。
局限性
- 证据来自小鼠模型与体外细胞实验,人体疗效与安全性未验证;RA全身作用及剂量相关信息未在摘要中报告。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Proliferation of glomerular epithelial cells, including podocytes, is a key histologic feature of crescentic glomerulonephritis. We previously found that retinoic acid (RA) inhibits proliferation and induces differentiation of podocytes by activating RA receptor-α (RARα) in a murine model of HIV-associated nephropathy. Here, we examined whether RA would similarly protect podocytes against nephrotoxic serum-induced crescentic glomerulonephritis and whether this effect was mediated by podocyte RARα. RA treatment markedly improved renal function and reduced the number of crescentic lesions in nephritic wild-type mice, while this protection was largely lost in mice with podocyte-specific ablation of Rara (Pod-Rara knockout). At a cellular level, RA significantly restored the expression of podocyte differentiation markers in nephritic wild-type mice, but not in nephritic Pod-Rara knockout mice. Furthermore, RA suppressed the expression of cell injury, proliferation, and parietal epithelial cell markers in nephritic wild-type mice, all of which were significantly dampened in nephritic Pod-Rara knockout mice. Interestingly, RA treatment led to the coexpression of podocyte and parietal epithelial cell markers in a small subset of glomerular cells in nephritic mice, suggesting that RA may induce transdifferentiation of parietal epithelial cells toward a podocyte phenotype. In vitro, RA directly inhibited the proliferation of parietal epithelial cells and enhanced the expression of podocyte markers. In vivo lineage tracing of labeled parietal epithelial cells confirmed that RA increased the number of parietal epithelial cells expressing podocyte markers in nephritic glomeruli. Thus, RA attenuates crescentic glomerulonephritis primarily through RARα-mediated protection of podocytes and in part through the inhibition of parietal epithelial cell proliferation and induction of their transdifferentiation into podocytes.
引用
- Dai Y, Chen A, Liu R, et al. Retinoic acid improves nephrotoxic serum-induced glomerulonephritis through activation of podocyte retinoic acid receptor α. Kidney Int. 2017. PMID: 28756872. doi:10.1016/j.kint.2017.04.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。